These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 8457236

  • 1. Effects of a dried garlic preparation on fibrinolysis and platelet aggregation in healthy subjects.
    Legnani C, Frascaro M, Guazzaloca G, Ludovici S, Cesarano G, Coccheri S.
    Arzneimittelforschung; 1993 Feb; 43(2):119-22. PubMed ID: 8457236
    [Abstract] [Full Text] [Related]

  • 2. Studies on the release of a plasminogen activator inhibitor by human platelets.
    Kruithof EK, Tran-Thang C, Bachmann F.
    Thromb Haemost; 1986 Apr 30; 55(2):201-5. PubMed ID: 2940723
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia.
    Pajkrt D, Lerch PG, van der Poll T, Levi M, Illi M, Doran JE, Arnet B, van den Ende A, ten Cate JW, van Deventer SJ.
    Thromb Haemost; 1997 Feb 30; 77(2):303-7. PubMed ID: 9157586
    [Abstract] [Full Text] [Related]

  • 6. Effects of garlic oil on platelet aggregation: a double-blind placebo-controlled crossover study.
    Wojcikowski K, Myers S, Brooks L.
    Platelets; 2007 Feb 30; 18(1):29-34. PubMed ID: 17365851
    [Abstract] [Full Text] [Related]

  • 7. Influence of triflusal on platelet activation after coronary artery bypass graft.
    Prieto MA, De La Cruz JP, Del Prado MF, Sánchez de la Cuesta F.
    Blood Coagul Fibrinolysis; 2000 Mar 30; 11(2):191-7. PubMed ID: 10759013
    [Abstract] [Full Text] [Related]

  • 8. Effects of long-acting propranolol and verapamil on blood pressure, platelet function, metabolic and rheological properties in hypertension.
    Ding YA, Chou TC, Lin KC.
    J Hum Hypertens; 1994 Apr 30; 8(4):273-8. PubMed ID: 8021907
    [Abstract] [Full Text] [Related]

  • 9. Platelet function and fibrinolytic activity in hypertension: differential effects of calcium antagonists and beta-adrenergic receptor blockers.
    Winther K, Gleerup G, Hedner T.
    J Cardiovasc Pharmacol; 1991 Apr 30; 18 Suppl 9():S41-4. PubMed ID: 1725542
    [Abstract] [Full Text] [Related]

  • 10. The COX-2 selective inhibitor, valdecoxib, does not impair platelet function in the elderly: results of a randomized controlled trial.
    Leese PT, Recker DP, Kent JD.
    J Clin Pharmacol; 2003 May 30; 43(5):504-13. PubMed ID: 12751271
    [Abstract] [Full Text] [Related]

  • 11. Piretanide: a new synthetic fibrinolytic and anti-platelet agent.
    Chohan IS.
    Thromb Haemost; 1986 Dec 15; 56(3):360-3. PubMed ID: 3563967
    [Abstract] [Full Text] [Related]

  • 12. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100.
    Homoncik M, Jilma B, Hergovich N, Stohlawetz P, Panzer S, Speiser W.
    Thromb Haemost; 2000 Feb 15; 83(2):316-21. PubMed ID: 10739392
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Aqueous extracts of onion, garlic and ginger inhibit platelet aggregation and alter arachidonic acid metabolism.
    Srivastava KC.
    Biomed Biochim Acta; 1984 Feb 15; 43(8-9):S335-46. PubMed ID: 6440548
    [Abstract] [Full Text] [Related]

  • 15. Effects of ticlopidine of platelet function in men with stable angina pectoris.
    Berglund U, von Schenck H, Wallentin L.
    Thromb Haemost; 1985 Dec 17; 54(4):808-12. PubMed ID: 3911481
    [Abstract] [Full Text] [Related]

  • 16. Influence of garlic powder on cutaneous microcirculation. A randomized placebo-controlled double-blind cross-over study in apparently healthy subjects.
    Jung EM, Jung F, Mrowietz C, Kiesewetter H, Pindur G, Wenzel E.
    Arzneimittelforschung; 1991 Jun 17; 41(6):626-30. PubMed ID: 1930351
    [Abstract] [Full Text] [Related]

  • 17. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S, Mangalpally K, Vaduganathan M, Patel R, Delao T, Bergeron AL, Dong JF, Lev EI, Kleiman NS.
    Thromb Haemost; 2008 Jul 17; 100(1):83-9. PubMed ID: 18612542
    [Abstract] [Full Text] [Related]

  • 18. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
    Zahavi J, Zahavi M.
    Thromb Haemost; 1985 Feb 18; 53(1):105-9. PubMed ID: 3158092
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA, Bliden KP, DiChiara J, Newcomer J, Weng W, Neerchal NK, Gesheff T, Chaganti SK, Etherington A, Tantry US.
    Circulation; 2007 Jun 26; 115(25):3156-64. PubMed ID: 17562955
    [Abstract] [Full Text] [Related]

  • 20. Coagulation, fibrinolytic and platelet function in patients on long-term therapy with aspirin 300 mg or 1,200 mg daily compared with placebo.
    Hampton KK, Cerletti C, Loizou LA, Bucchi F, Donati MB, Davies JA, de Gaetano G, Prentice CR.
    Thromb Haemost; 1990 Aug 13; 64(1):17-20. PubMed ID: 2073296
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.